Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

3.5 mm Cypher Availability To Reduce Problems With Over-Expansion – Cordis

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson/Cordis says it will meet U.S. hospitals' orders for the Cypher drug-eluting stent by the end of the year, when Boston Scientific's Taxus drug-eluting stent is expected to reach the U.S. market

You may also be interested in...



FDA’s Kessler Pitches “Foreseeable Risk” Analysis As Way To Speed Reviews

Forthcoming guidances by CDRH will encourage the inclusion of risk analyses in 510(k) product development, according to Office of Science & Engineering Laboratories Director Larry Kessler

FDA’s Kessler Pitches “Foreseeable Risk” Analysis As Way To Speed Reviews

Forthcoming guidances by CDRH will encourage the inclusion of risk analyses in 510(k) product development, according to Office of Science & Engineering Laboratories Director Larry Kessler

Antiplatelet Drug Compliance May Avert DES Thrombosis; Cypher Events Over?

Late thrombosis in drug-eluting stents can be curbed if more physicians acknowledge the need for sustained antiplatelet therapy in patients post-implant, Mark Eisenberg, MD, Jewish General Hospital in Montreal, asserts in the Oct. 23 issue of The Lancet

Related Content

UsernamePublicRestriction

Register

MT018678

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel